Sangamo Therapeutics
SGMO
HK$4.71
Share price
2.46%
Change (1 day)
-34.46%
Change (1 year)
Sangamo Therapeutics (SGMO) - Total debt
Total debt on the balance sheet as of March 2025 : HK$0.19 Billion
According to Sangamo Therapeutics 's latest financial reports the company's total debt is HK$0.19 Billion. A company’s total debt is the sum of all current and non-current debts.
Sangamo Therapeutics - Total debt on balance sheet (from 2000 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | HK$0.23 B | -20.26% |
| 2023-12-31 | HK$0.29 B | -11.64% |
| 2022-12-31 | HK$0.33 B | -10.16% |
| 2021-12-31 | HK$0.37 B | 14.91% |
| 2020-12-31 | HK$0.32 B | -5.66% |
| 2019-12-31 | HK$0.34 B | 59.5% |
| 2018-12-31 | HK$0.21 B | 12.19% |
| 2017-12-31 | HK$0.19 B | 531.79% |
| 2016-12-31 | HK$30.59 M | |
| 2015-12-31 | N/A | |
| 2001-12-31 | HK$2.22 M | |
| 1999-12-31 | HK$2.33 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | HK$195.85 B | 100,205.52% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | HK$10.21 B | 5,132.51% | 🇺🇸 USA |
 Amgen AMGN | HK$450.39 B | 230,568.11% | 🇺🇸 USA |
 Biogen BIIB | HK$51.97 B | 26,516.82% | 🇺🇸 USA |
 Dow DOW | HK$140.66 B | 71,941.32% | 🇺🇸 USA |
 Johnson & Johnson JNJ | HK$410.13 B | 209,949.85% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | HK$4.72 B | 2,319.84% | 🇺🇸 USA |
 Merck MRK | HK$273.49 B | 139,970.75% | 🇺🇸 USA |